NCT06730100 2025-10-06CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal CancerNational Cancer Institute (NCI)Phase 2 Withdrawn
NCT04535401 2024-10-10Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesNational Cancer Institute (NCI)Phase 1 Active not recruiting10 enrolled